
Abdirizak Abdullahi Sheikdon,1 Abdishakor Mohamud Ahmed,2,3 Abdullahi Hassan Elmi3,4 1Department of Orthopaedics, Royal Hospital, Somali National University, Mogadishu, Somalia; 2Department of Orthopaedics, Royal Hospital, Mogadishu, Somalia; 3Faculty of Medicine and Health Sciences, SIMAD University, Mogadishu, Somalia; 4Department of Nursing and Midwifery, Dr. Sumait Hospital, SIMAD University, Mogadishu, SomaliaCorrespondence: Abdullahi Hassan Elmi, Email aarrkaa@gmail.comBackground: Orthopaedic surgeons may encounter occupational, clinical, and institutional challenges when providing surgical care to patients living with HIV. In Somalia, evidence concerning surgeons’ attitudes, practices, and experiences in managing these patients remains limited. This study aimed to assess HIV-related care practices, attitudes, and perceived challenges among orthopaedic surgeons practising in Somalia.Methods: A descriptive cross-sectional survey was conducted between January and April 2025. A census-based sampling approach was used to invite 33 identified eligible orthopaedic surgeons, all of whom completed the survey, yielding a response rate of 100%. Data were collected using a structured, self-administered questionnaire covering demographic characteristics, institutional policies, attitudes, clinical practices, training, and perceived challenges. The questionnaire underwent expert review by five healthcare professionals and was pilot tested among five orthopaedic surgeons who were excluded from the final sample. Data were analyzed using descriptive statistics and presented as frequencies and percentages.Results: Most respondents were aged 30– 40 years (n = 23, 69.7%), followed by those aged above 40 years (n = 6, 18.2%) and those younger than 30 years (n = 4, 12.1%). Thirty surgeons (90.9%) reported mandatory preoperative HIV testing, while only seven (21.2%) reported that their hospitals had written protocols for operating on patients living with HIV. Twenty-two respondents (66.7%) had previously performed surgery on patients living with HIV, and 21 (63.6%) reported managing these patients similarly to other patients while applying appropriate precautions. However, ten respondents (30.3%) preferred referring patients to another provider or facility. Inadequate resources (84.8%), concerns about occupational transmission (78.8%), and insufficient knowledge or training (45.5%) were frequently reported challenges. Stigma and discrimination were also identified as challenges by 45.5% of respondents.Conclusion: The findings highlight reported gaps in institutional guidance, protective resources, and HIV-related professional training among participating orthopaedic surgeons in Somalia. Strengthening infection prevention procedures, occupational health support, and professional education may help improve the consistency and safety of surgical care. However, the small sample size, self-reported data, and descriptive design limit the generalizability of the findings and do not establish the reasons underlying clinical preferences. Further research is needed to inform broader improvements in HIV-related orthopaedic care.Keywords: HIV/AIDS care, orthopaedic surgeons, clinical practice, infection prevention, occupational exposure, resource-limited settings, Somalia
Emmanuel Ndahiro Manirafasha,1 Marguerite Mukarugwiza21Center for Nursing and Midwifery, University of Global Health Equity, Kigali, Rwanda; 2Department of Nursing and Midwifery, Adventist University of Central Africa, Kigali, RwandaCorrespondence: Emmanuel Ndahiro Manirafasha, Center for Nursing and Midwifery, University of Global Health Equity, Kigali, Rwanda, Tel +250788887265, Email emmyndahiro14@gmail.comAbstract: Rwanda has made substantial progress in HIV diagnosis, treatment, and viral suppression. However, these achievements do not necessarily reflect the mental health and psychosocial well-being of people living with HIV (PLHIV). Evidence from Rwanda indicates that mental health disorders remain underrecognized and undertreated, even among individuals achieving favorable HIV treatment outcomes. Although national HIV guidelines recommend routine mental health screening and referral, there is limited evidence on how consistently these recommendations are implemented across HIV services. This Perspective argues that the priority is not simply to advocate for mental health integration, but to make existing recommendations work in everyday clinical practice. Drawing on Rwanda’s experience with decentralized healthcare, task sharing, and supportive supervision, we propose a practical approach that connects mental health screening with appropriate assessment, first-line psychosocial support, referral, and follow-up. Key priorities include strengthening frontline provider competencies, establishing clear responsibilities across levels of care, involving PLHIV in service design, and monitoring whether patients receive appropriate support. These actions should be introduced progressively and evaluated for feasibility, acceptability, continuity of care, and sustainability. Strengthening mental health integration does not require specialist services in every ART clinic; it requires a coordinated system in which mental health needs are recognized, and patients can access appropriate care. Moving from policy recommendations to measurable improvements in service delivery is essential to advancing person-centered HIV care in Rwanda.Keywords: mental health, HIV care, mental health integration, people living with HIV, Rwanda, health service delivery
AliAkbar Haghdoost,1 Mostafa Hosseini Golkar,1 Hamid Sharifi,2,3 Farid Najafi,4 Alireza Alikhani51Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran; 2HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran; 3Institute for Global Health Sciences, University of California, San Francisco, CA, USA; 4Research Center for Environmental Determinants of Health, Research Institute for Health, Kermanshah University of Medical Sciences, Kermanshah, Iran; 5Social Development and Health Promotion Research Center, Health Policy and Promotion Institute, Kermanshah University of Medical Sciences, Kermanshah, IranCorrespondence: Alireza Alikhani, Email alirezaalikhani8687@gmail.comIntroduction: Despite substantial progress in the global HIV response, the MENA region continues to face important challenges in HIV prevention and control. In Iran, fluctuations in the number of newly diagnosed HIV cases indicate an ongoing public health challenge and underscore the need to anticipate factors that may shape future diagnosis patterns.Methods: This study applied Trend Impact Analysis (TIA) to develop conditional projections of newly diagnosed HIV cases in Iran through 2030. Monthly surveillance data from 1998 to 2023 were modeled using an ARIMA(2,0,2) to establish a baseline trend which was subsequently modified through TIA based on expert-informed estimates of the timing and magnitude of key drivers. A panel of 30 experts in HIV/AIDS, epidemiology, public health, and health policy identified and assessed key drivers that could influence future trends. Expert- informed estimates of the timing, magnitude, and persistence of impacts, were then incorporated into the baseline projection to construct alternative future scenarios.Results: Expert panels identified 13 key drivers: eight adverse influences, including conflict risk, increased sex work, new stimulant drug use, online sexual platforms, socioeconomic crises, emerging epidemics, developing sex tourism, and HIV drug resistance, expected to increase the future number of newly diagnosed HIV cases. Conversely, five positive influences, including AI healthcare, effective vaccination access, efficient surveillance toward the 95– 95-95 objectives, PEP/PrEP implementation, and advanced therapies, expected to reduce the future number of newly diagnosed HIV cases. Quantitative estimates project 1698 new cases if current trends persist. Under optimistic scenarios, cases may decline by 51%, whereas pessimistic scenarios suggest an increase of 102%. The integrated TIA scenario projected an approximately 51% increase in newly diagnosed HIV cases by 2030, reaching 2558 cases by 2030, with an approximate 95% uncertainty interval of 2120– 2996 (± 2 SD).Conclusion: The scenario projections represent conditional future trajectories based on specified assumptions about the impact of different key drivers, The scenarios illustrate substantial uncertainty in the future number of newly diagnosed HIV cases in Iran, with scenario estimates ranging from approximately a 50% decrease to a 100% increase relative to the baseline projection.Keywords: health futures studies, trend impact analysis, scenario analysis, HIV/AIDS
Arinaitwe Medard,1,2 Mwesigwa Geoffrey,2,3 Asiimwe Derrick,3 Ikiriza Anthony,4 Muyindike Winnie,2,5 Stephen Asiimwe11Department of Community Health, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda; 2Immune Suppression Syndrome Clinic, Mbarara Regional Referral Hospital, Mbarara, Uganda; 3Department of Physiology, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda; 4Department of Public Health, Faculty of Health Sciences, Mountains of the Moon University, Fort Portal, Uganda; 5Department of Internal Medicine, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, UgandaCorrespondence: Arinaitwe Medard, Immune Suppression Syndrome Clinic, Mbarara Regional Referral Hospital, P. O. Box 40, Mbarara, Uganda, Tel +256 702923293, Email medarinaitwe@gmail.comBackground: Dolutegravir (DTG)-based antiretroviral therapy is widely used in sub-Saharan Africa, but routine-care evidence on incident hyperglycemia after DTG initiation or substitution remains limited in southwestern Uganda.Purpose: To determine the incidence and predictors of documented hyperglycemia among adults receiving DTG-based antiretroviral therapy at Mbarara Regional Referral Hospital.Patients and Methods: We conducted a retrospective cohort study using routine clinical records of adults who initiated or switched to DTG-based ART between 1 January 2019 and 31 December 2023. Documented incident hyperglycemia was defined as fasting glucose ≥ 7.0 mmol/L or random glucose ≥ 11.1 mmol/L with documented classic symptoms. Cox proportional hazards regression estimated adjusted hazard ratios (aHRs); age was modeled per 10-year increase. The proportional-hazards assumption was assessed using Schoenfeld residuals.Results: Of 8,859 adults in the descriptive cohort, 8,856 contributed positive follow-up time. Seventy-four documented hyperglycemia events occurred over 29,157.74 person-years, an incidence rate of 2.54 per 1,000 person-years (95% CI 1.99– 3.19). The smoothed hazard increased after DTG initiation/substitution, peaked at approximately 1.1 years, and declined thereafter. Higher hazard was associated with older age (per 10 years: aHR 1.70, 95% CI 1.33– 2.18), prior thymidine analogue NRTI exposure (aHR 3.27, 95% CI 1.20– 8.89), and ≥ 15 years of ART before DTG (aHR 5.63, 95% CI 1.39– 22.77). The global proportional-hazards test was not significant (p=0.70).Conclusion: Documented hyperglycemia was uncommon but was associated with older age and markers of long-term ART exposure. Risk-stratified glucose monitoring should be considered, particularly during the first year after DTG initiation/substitution and among higher-risk patients.Keywords: dolutegravir, hyperglycemia, HIV, antiretroviral therapy, incidence, predictors, cox regression, Uganda
Emmanuel Ndahiro ManirafashaCenter for Nursing and Midwifery, University of Global Health Equity, Kigali, RwandaCorrespondence: Emmanuel Ndahiro Manirafasha, Center for Nursing and Midwifery, University of Global Health Equity, Kigali, Rwanda, Tel +250788887265, Email emmyndahiro14@gmail.comAbstract: Nurses are central to HIV testing, treatment, prevention, differentiated service delivery, and increasingly integrated care. However, expanding their clinical responsibilities without corresponding leadership preparation, decision-making authority, and institutional support risks creating symbolic rather than effective leadership. This Viewpoint argues that the next phase of the HIV response requires prepared and accountable nurse leaders who can use program data, redesign workflows, strengthen referral systems, support quality improvement, and contribute to policy and resource decisions. Accountability must be reciprocal: nurse leaders should be responsible for quality, equity, patient experience, and workforce well-being, while institutions must provide adequate staffing, mentorship, reliable supplies, usable data, and enabling scopes of practice. Ministries, regulators, implementing partners, and HIV governance bodies should establish competency-based leadership preparation, align authority with responsibility, include nurses in decision-making, and involve communities in service design. Nursing leadership should be treated as essential HIV program infrastructure, not optional professional development.Keywords: nursing leadership, HIV response, professional accountability